Skip to content

Homoeopathy for Vitamin D deficiency: a public health program

Public health program to assess the prevalence of Vitamin-D deficiency and its management with homoeopathic medicine - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085258
Enrollment
1600
Registered
2025-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E55- Vitamin D deficiency

Interventions

Intervention1: Individualised Homoeopathic Medicine: The individualized homoeopathic medicines (As per Homoeopathic pharmacopoeia of India/ materia medica) manufactured by Good Manufacturing Practice

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals coming to the medical camps for health checkups. Children aged 6 to 17 years, and adult individuals aged 18 to 65 years of both sexes. Persons willing to participate in the program and give consent (6 years to less than 12 years shall provide verbal assent & consent of parent also their parent or guardian can answer the questions for them, 12 years to less than 18 years shall provide written assent and consent of parent and adults of 18 to 65 years shall provide written consent) to draw blood for further examinations. Persons who can be interviewed directly and who can respond to the questions of the survey Persons with vitamin D Insufficiency (more than 20 to less than 30 ng/ml)

Exclusion criteria

Exclusion criteria: Persons above 65 years of age Persons with self-reported severe bleeding disorders such as haemophilia or thrombocytopenia, or Anticoagulant Medication (currently or in the last 3 months) Participants exhibiting symptoms of active infection, such as fever, chills, or localized signs of infection at the venipuncture site. Participants with severe deficiency of Vitamin D (less than 5 ng/ml), Moderate deficiency (6-19 ng/ml) and toxicity Participants unable to come for regular follow-ups for a minimum of two follow-ups. Participants refusing consent for the homoeopathic treatment. Pregnant and lactating women. Persons with identified Hepato-renal conditions

Design outcomes

Primary

MeasureTime frame
Change in serum Vitamin-D levelsTimepoint: Baseline, at 6 months and at 12 months

Secondary

MeasureTime frame
prevalence of Vitamin D levelsTimepoint: baseline;Change in serum Calcium levelsTimepoint: baseline, at 6 months and at 12 months;Change in serum Phosphate levelsTimepoint: Baseline, at 6 months and at 12 months;Change in serum Magnesium levelsTimepoint: Baseline, at 6 months and at 12 months;Change in serum Uric Acid levelsTimepoint: Baseline, at 6 months and at 12 months;Change in Alkaline Phospatase levelsTimepoint: Baseline, at 6 months and at 12 months

Countries

India

Contacts

Public ContactDr Divya Taneja

Central Council for Research in Homoeopathy

renumittal8@gmail.com9717511115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026